Pine Bridge Investments, L.P. Arrowhead Pharmaceuticals, Inc. Transaction History

Pine Bridge Investments, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$20.56 - $63.12 $156,420 - $480,216	-7,608 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$28.14 - $73.01 $1.7 Million - $4.41 Million	-60,451 Reduced 88.82%	7,608 $483,000
Q3 2019 Nov 13, 2019	BUY	$26.26 - $34.86 $35,897 - $47,653	1,367 Added 2.05%	68,059 $1.92 Million
Q2 2019 Aug 13, 2019	BUY	$17.43 - $28.82 $1.16 Million - $1.92 Million	66,692 New	66,692 $1.77 Million

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.